ReviewBiosensors & bioelectronics: X2022

FDA authorized molecular point-of-care SARS-CoV-2 tests: A critical review on principles, systems and clinical performances.

Brigitte Bruijns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.